Tressa Allington, Ph.D., Development Scientist, Bioanalytical Development, Alexion Pharmaceuticals
Robyn Beckwith, Ph.D., Associate Scientist, Analytical Development and Quality Control, Product Technical Development, Genentech
Anne Benoit, Ph.D., Expert Biostatistician, Biostatistics and Statistical Programming, Non-Clinical R&D Statistics – CLS, Clinical Evidence Generation, GSK Vaccines
Erica Bortolotto, Ph.D., Senior Scientist, Bioassay Development, Analytical Sciences for Biologicals, UCB PHARMA
Xiaoying Chen, Ph.D., Senior Manager, Early Oncology Development & Clinical Research, Pfizer, Inc.
Shan Chung, Ph.D., Senior Scientist and Group Leader, BioAnalytical Sciences, Genentech, Inc.
Jim Cook, Immunology Sales Specialist, Sales, ProImmune Inc
Viswanath Devanarayan, Ph.D., Executive Director and Head, Global Statistics, Charles River Labs
Rakesh Dixit, Ph.D., Vice President, R&D, Global Head, Biologics Safety Assessment, MedImmune, Inc.
Mark Fogg, Group Leader, Immunology, Abzena
Jochem Gokemeijer, Ph.D., Associate Director, Molecular Discovery Technology, Bristol-Myers Squibb
Theresa Goletz, Ph.D., Director, Clinical Immunology, EMD Serono
Ulrike Herbrand, Ph.D., Scientific Supervisor Research & Development, Biosafety & Bioassay Services, Charles River Labs
Vibha Jawa, Ph.D., Director, Biologics and Vaccines Bioanalytics, Merck and Co., Inc.
Marisa K. Joubert, Ph.D., Principal Scientist, Process Development, Amgen, Inc.
Martin Kane, MS, CRE, Managing Data Scientist, Statistical and Data Sciences Practice, Exponent
Susan Kirshner, Ph.D., Associate Chief, Immunology Lab, Therapeutic Proteins, Biotechnology, FDA/CDER
Kei Kishimoto, Ph.D., CSO, Selecta Biosciences
Priya S. Kishnani, M.D., Division Chief & Director, Genetics and Genomics Center, Department of Pediatrics, Duke University
Jennifer Koenitzer, Ph.D., Research Investigator, Discovery Biology, Immuno-Oncology Drug Discovery, Bristol-Myers Squibb
Natalia Kozhemyakina, Ph.D., Head, Bioassay Laboratory, Analytical Development Department, BIOCAD
Robert J. Kubiak, Ph.D., Senior Manager, R&D, Translational Science, MedImmune LLC
Steven J. Kussick, M.D., Ph.D., Associate Medical Director, Director, Contract Research and Flow Cytometry, PhenoPath Laboratories; Clinical Assistant Professor, Laboratory Medicine, University of Washington
Mike Lacy, Ph.D., Associate Director, Immunology, Emergent Biosolutions
David Lansky, Ph.D., President, Precision Bioassay, Inc.
Maria Libera Ascierto, Ph.D., Post Doc Fellow, Oncology, Johns Hopkins University
Thomas Little, Ph.D., President, Bioassay Sciences, Thomas A. Little Consulting
LeeAnn Machiesky, Scientist, MedImmune
Mauricio Maia, Ph.D., Senior Scientist, BioAnalytical Sciences, Genentech, Inc.
David Margulies, M.D., Ph.D., Senior Investigator, Molecular Biology, Niaid/DIR
Rachid Marhaba, Ph.D., Senior Scientist, Clinical Laboratory Sciences, GSK Vaccines GmbH
Ronit Mazor, Ph.D., Post-Doctoral Fellow, Molecular Biology, National Cancer Institute
Jim McNally, Ph.D., Head, Clinical Bioanalysis and QPD Program Rep, Quantitative Pharmacology and Drug Disposition, EMD Serono
Keith Merdek, Ph.D., Principal Scientist, Bioanalytical Sciences & Biomarkers, Sanofi
Paul Moore, Ph.D., Vice President, Cell Biology & Immunology, Macrogenics, Inc.
Tony Navas, Ph.D., Senior Scientist, Clinical Pharmacodynamic Biomarkers Program, Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research
Jennifer Ohayon, Ph.D., Scientific Director, Eurofins Bioanalytical Services
Michael Partridge, Ph.D., Staff Scientist, Bioanalytical Sciences, Regeneron, Inc.
Ravish Patel, Ph.D., Scientist, Analytical Development Lab, EPR Centre for Cancer Research & Bioinformatics Pvt. Ltd. (A Vitane Group company)
Sofie Pattijn, CTO, ImmunXperts
Joao Pedras-Vasconcelos, Ph.D., Biotech Quality and Immunogenicity Reviewer, Office of Biotechnology Products, CDER-FDA
Alpana Prasad, Ph.D., Product Manager, DiscoverX Corporation
Kathleen P. Pratt, Ph.D., Associate Professor, Medicine, Uniformed Services, University of the Health Sciences
Matthew Roberts, Ph.D., Investigator, Biopharmaceutical and Analytical Sciences, GlaxoSmithKline
Amy S. Rosenberg, M.D., Division Director, Office of Biotechnology Products, FDA/CDER
Bonita (Bonnie) Rup, Ph.D., Biopharmaceutical Consultant, Bonnie Rup Consulting
Laura I. Salazar-Fontana, Ph.D., Associate Director, Biomarkers and Clinical Bioanalysis, Translational Medicine and Early Development, Sanofi
Becky Schweighardt, Ph.D., Director, Immunogenicity Assessment, Biomarin Pharmaceutical, Inc.
Ethan Shevach, M.D., Senior Investigator, Immunology, National Institute of Allergy and Infectious
Diseases, National Institutes of Health
Noel Smith, Ph.D., Senior Group Leader, Applied Protein Services, Lonza Biologics, plc
Veerle Snoeck, Ph.D., Principal Scientist, Pharmacology, Immunogenicity, Ablynx BV
Perceval Sondag, Principal Statistician, Non-Clinical Statistics, Arlenda
Priya Sriraman, Ph.D., Principal Investigator, Non-Clinical Development, Celgene Corp
Lauren Stevenson, Ph.D., Director, Development Biomarkers and Bioanalytical Sciences, Biogen, Inc.
Sandra Thiemann, Ph.D., Scientist, Bio-Immunoassay Group, Attribute Sciences, Amgen
Daniela Verthelyi, Ph.D., Chief, Immunology Lab, Therapeutic Proteins, FDA/CDER
Junxia Wang, Ph.D., Associate Director, Immunosafety and Bioanalytical Development, Editas Medicine
Wendy White, Ph.D., Scientific Director & Fellow, Clinical Pharmacology, MedImmune, Inc.
Yuanxin Xu, Ph.D., Senior Scientific Director, Clinical Assay Development, Clinical Lab Sciences, Alnylam Pharmaceuticals
Rong Zeng, Ph.D., Director, Bioanalytical Sciences, OncoMed Pharmaceuticals
Jad Zoghbi, Ph.D., Senior Scientist, Biomarkers and Clinical Bioanalysis, Sanofi